In the ApcMin/+ mouse model, an IL-33 deficiency reduced tumor burden [177] and decreased mast cell density in the colonic polyps, as well as suppressed the gene expression of mast cell proteases and cytokines that promote angiogenesis, Treg function, and MDSC recruitment within the TME [178,179,180]. This evidence concerns the gene IL33 and neoplasm.